KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis
USA - NASDAQ:KEQU - US4928541048 - Common Stock
43.19 USD
+0.69 (+1.62%)
43.19 USD
0 (0%)
Overall KEQU gets a fundamental rating of 5 out of 10. We evaluated KEQU against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year KEQU was profitable.
In the past year KEQU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.36%, KEQU belongs to the top of the industry, outperforming 86.39% of the companies in the same industry.
KEQU has a better Return On Equity (18.34%) than 92.67% of its industry peers.
KEQU has a Return On Invested Capital of 10.92%. This is amongst the best in the industry. KEQU outperforms 91.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 8.88%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROIC | 10.92% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of KEQU (4.68%) is better than 76.44% of its industry peers.
Looking at the Operating Margin, with a value of 7.60%, KEQU is in the better half of the industry, outperforming 75.92% of the companies in the same industry.
With a Gross Margin value of 29.37%, KEQU is not doing good in the industry: 75.39% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of KEQU has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
Compared to 1 year ago, KEQU has about the same amount of shares outstanding.
KEQU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KEQU is higher compared to a year ago.
2.2 Solvency
KEQU has an Altman-Z score of 3.15. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KEQU (3.15) is better than 68.59% of its industry peers.
KEQU has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as KEQU would need 3.45 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.45, KEQU belongs to the best of the industry, outperforming 85.34% of the companies in the same industry.
A Debt/Equity ratio of 0.91 indicates that KEQU is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.91, KEQU is not doing good in the industry: 75.39% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 3.15 |
ROIC/WACC1.41
WACC7.76%
2.3 Liquidity
A Current Ratio of 2.32 indicates that KEQU has no problem at all paying its short term obligations.
KEQU has a Current ratio (2.32) which is in line with its industry peers.
KEQU has a Quick Ratio of 1.63. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, KEQU is in line with its industry, outperforming 44.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 |
3. Growth
3.1 Past
The earnings per share for KEQU have decreased strongly by -33.65% in the last year.
Looking at the last year, KEQU shows a very strong growth in Revenue. The Revenue has grown by 30.09%.
Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.43, which indicates a very decent valuation of KEQU.
Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 91.62% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.42. KEQU is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.43 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KEQU is valued cheaper than 96.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, KEQU is valued cheaply inside the industry as 98.43% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.63 | ||
| EV/EBITDA | 6.61 |
4.3 Compensation for Growth
The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for KEQU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
43.19
+0.69 (+1.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner Change0%
Ins Owners16.53%
Ins Owner Change1.44%
Market Cap123.96M
Analysts82.86
Price TargetN/A
Short Float %2.16%
Short Ratio4.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.43 | ||
| Fwd PE | N/A | ||
| P/S | 0.47 | ||
| P/FCF | 6.63 | ||
| P/OCF | 5.8 | ||
| P/B | 1.85 | ||
| P/tB | 3.34 | ||
| EV/EBITDA | 6.61 |
EPS(TTM)4.14
EY9.59%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY15.09%
OCF(TTM)7.45
OCFY17.24%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.36% | ||
| ROE | 18.34% | ||
| ROCE | 13.98% | ||
| ROIC | 10.92% | ||
| ROICexc | 12.63% | ||
| ROICexgc | 16.65% | ||
| OM | 7.6% | ||
| PM (TTM) | 4.68% | ||
| GM | 29.37% | ||
| FCFM | 7.11% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.38 | ||
| Cap/Depr | 48.41% | ||
| Cap/Sales | 1.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.84% | ||
| Profit Quality | 152.04% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.63 | ||
| Altman-Z | 3.15 |
F-Score4
WACC7.76%
ROIC/WACC1.41
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%